Ascendis Pharma A (ASND) Non-cash Items (2015 - 2026)

Ascendis Pharma A (ASND) has 12 years of Non-cash Items data on file, last reported at -$9.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 48.69% year-over-year to -$9.5 million; the trailing twelve-month figure through Mar 2026 stood at -$132.9 million (up 42.16% YoY), and the FY2025 full-year result was -$143.8 million, up 55.69% from the prior year.
• Non-cash Items improved to -$9.5 million in Q1 2026, from -$130.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $4.6 million in Q3 2025 to a low of -$163.1 million in Q2 2023.
• A 5-year average of -$88.2 million and a median of -$101.6 million in 2022 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items slumped 49.32% in 2022 and jumped 107.31% in 2025, its largest moves.
• Tracing ASND's Non-cash Items over 5 years: stood at -$101.6 million in 2022, then tumbled by 36.76% to -$138.9 million in 2023, then jumped by 35.51% to -$89.6 million in 2024, then slumped by 45.59% to -$130.4 million in 2025, then surged by 92.75% to -$9.5 million in 2026.
• Business Quant data shows ASND's Non-cash Items at -$9.5 million in Q1 2026, -$130.4 million in Q4 2025, and $4.6 million in Q3 2025.